Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2001;60:1131-1136; doi:10.1136/ard.60.12.1131
Copyright © 2001 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2001;60:1131-1136 ( December )

Extended report

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing I Peenea, L Meheusb, E M Veysa, F De Keysera

a Department of Rheumatology, Ghent University Hospital, Belgium, b Innogenetics NV, Ghent, Belgium

Correspondence to: Dr F De Keyser, Department of Rheumatology 0K12IB, University Hospital Ghent, De pintelaan 185, 9000 Ghent, Belgium filip.dekeyser{at}rug.ac.be

Accepted for publication 3 May 2001

OBJECTIVE---To provide data on (a) the probability of detecting antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing and (b) the probability of detecting more specific antinuclear reactivities (anti-DNA and anti-extractable nuclear antigens (anti-ENA)) in serum samples with a positive screening test (indirect immunofluorescence on HEp-2 cells).
METHODS---Serum samples from 10 550 consecutive patients sent to the laboratory for ANA detection were analysed. In ANA positive serum samples (23.5% of referred serum samples), ANA were identified by indirect immunofluorescence on Crithidia, by immunodiffusion, and by line immunoassay. Because anti-SSA antibodies were the most frequently identified ANA, sensitively detected by line immunoassay, additional immunoassays were developed to confirm the specificity of the line immunoassay result.
RESULTS---At least one fine reactivity could be identified in 21.1% of ANA positive serum samples: anti-dsDNA in 3.2%; anti-ENA (anti-SSA 10.5%, anti-SSB 6.7%, anti-RNP 2.7%, anti-Sm 1.8%, anti-Scl70 1.2%, anti-Jo-1 0.2%) in 15.8%, rRNP and anti-Cenp-B in respectively 0.5% and 4.0%. Multiple reactivities were found in 7.9%. For anti-ENA antibodies, line immunoassay was more sensitive than immunodiffusion (15.4% v 7.7%; p<0.0001). The sensitive detection of anti-SSA antibodies by line immunoassay was confirmed by additional assays.
CONCLUSIONS---The data from this analysis are useful in estimating the probabilities of detecting specific ANA. Line immunoassay was shown to be a sensitive test for the detection of anti-ENA antibodies.


© 2001 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Smith, V, Vanthuyne, M, Vander Cruyssen, B, Van Praet, J, Vermeiren, F, Smets, H, Houssiau, F, De Keyser, F (2008). Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis 67: 1448-1450 [Abstract] [Full Text]  
  • Binder, S. (2006). Autoantibody Detection Using Multiplex Technologies. Lupus 15: 412-421 [Abstract]  
  • Pham, B-N, Albarede, S, Guyard, A, Burg, E, Maisonneuve, P (2005). Impact of external quality assessment on antinuclear antibody detection performance. Lupus 14: 113-119 [Abstract]  
  • Hoffman, I E A, Peene, I, Meheus, L, Huizinga, T W J, Cebecauer, L, Isenberg, D, De Bosschere, K, Hulstaert, F, Veys, E M, De Keyser, F (2004). Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63: 1155-1158 [Abstract] [Full Text]  
  • Hoffman, I. E.A., Peene, I., Veys, E. M., De Keyser, F. (2002). Detection of Specific Antinuclear Reactivities in Patients with Negative Anti-nuclear Antibody Immunofluorescence Screening Tests. Clin. Chem. 48: 2171-2176 [Abstract] [Full Text]  
  • Peene, I, Meheus, L, Veys, E M, De Keyser, F (2002). Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis 61: 1090-1094 [Abstract] [Full Text]  
  • Peene, I, Meheus, L, De Keyser, S, Humbel, R, Veys, E M, De Keyser, F (2002). Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 61: 929-933 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs